The effect of selective serotonin reuptake inhibitors on cognitive function in patients with Alzheimer’s disease and vascular dementia: focusing on fluoxetine with long follow-up periods
Open Access
- 30 August 2019
- journal article
- letter
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 4 (1), 1-3
- https://doi.org/10.1038/s41392-019-0064-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- History and progress of hypotheses and clinical trials for Alzheimer’s diseaseSignal Transduction and Targeted Therapy, 2019
- Increased Risk of Dementia in Patients with Antidepressants: A Meta-Analysis of Observational StudiesBehavioural Neurology, 2018
- The effect of treatment with selective serotonin reuptake inhibitors in comparison to placebo in the progression of dementia: a systematic review and meta-analysisAge and Ageing, 2016
- Effects of fluoxetine on brain-derived neurotrophic factor serum concentration and cognition in patients with vascular dementiaClinical Interventions in Aging, 2014
- Effect of Selective Serotonin Reuptake Inhibitors in Alzheimer’s Disease with Comorbid DepressionDrugs & Aging, 2012
- Antidepressants and dementiaJournal of Affective Disorders, 2009
- Does Serotonin Augmentation Have Any Effect on Cognition and Activities of Daily Living in Alzheimer's Dementia?Journal of Clinical Psychopharmacology, 2007
- Does Fluoxetine Have Any Effect on the Cognition of Patients With Mild Cognitive Impairment?Journal of Clinical Psychopharmacology, 2007